Testing effectiveness (Phase 2)Study completedNCT00846833What this trial is testingHaploidentical NK Cell Infusion in Malignant MelanomaWho this might be right forMelanoma Seoul National University Hospital 12
Not applicableStudy completedNCT06450743What this trial is testingAge-matched Reference Values for Circulating Natural Killer T-like CellsWho this might be right forHealthy Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40
Testing effectiveness (Phase 2)Ended earlyNCT04347616What this trial is testingNatural Killer-cell Therapy for Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, Relapsed, Adult Radboud University Medical Center 9
Testing effectiveness (Phase 2)Ended earlyNCT02621333What this trial is testingChemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaWho this might be right forLung Adenocarcinoma Henan Cancer Hospital 280
Early research (Phase 1)UnknownNCT06568328What this trial is testingChimeric Natural Killer Receptor-Universal T Cells for Refractory GVHDWho this might be right forGraft vs Host Disease Fujian Medical University 17
Not applicableStudy completedNCT01390116What this trial is testingThe Effect of Aged Garlic Extract Supplementation on Immune SystemWho this might be right forImprovement in Immune Cell Function in Healthy Humans University of Florida 120
Testing effectiveness (Phase 2)Looking for participantsNCT06158828What this trial is testingPilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AMLWho this might be right forAML, ChildhoodAmlAcute Myeloid Leukemia, Pediatric+1 more Washington University School of Medicine 68
Testing effectiveness (Phase 2)Study completedNCT03007875What this trial is testingHigh-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Metastatic Fuda Cancer Hospital, Guangzhou 20
Post-approval studies (Phase 4)UnknownNCT03208998What this trial is testingThe Changes of Natural Killer Cells Frequency and Function During Antiviral TherapyWho this might be right forChronic Hepatitis B Infection Beijing Ditan Hospital 100
Early research (Phase 1)Study completedNCT03515252What this trial is testingStudy of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung CancerWho this might be right forNSCLC Stage IIIBNSCLC Stage IVHepatocellular Carcinoma by BCLC Stage+2 more Ivy Life Sciences, Co., Ltd 20
Testing effectiveness (Phase 2)Looking for participantsNCT05503134What this trial is testingSafety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AMLWho this might be right forAcute Myeloid Leukemia Nationwide Children's Hospital 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT02496988What this trial is testingEffect of Cytokine-induced Killer Cells for Advanced Malignant GliomasWho this might be right forCytokine-Induced Killer CellsAdvanced Milignant Gliomas The First People's Hospital of Changzhou 120
Testing effectiveness (Phase 2)Study completedNCT00448201What this trial is testingReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)Ended earlyNCT03387085What this trial is testingQUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.Who this might be right forTriple Negative Breast Cancer ImmunityBio, Inc. 9
Testing effectiveness (Phase 2)UnknownNCT02705508What this trial is testingPEG-ASP, Etoposide and Gemcitabine for Natural Killer/T LymphomaWho this might be right forTreatment Refusal Sun Yat-sen University 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04414540What this trial is testingCombining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer PatientsWho this might be right forHead and Neck Squamous Cell Carcinoma Trisha Wise-Draper 21
Early research (Phase 1)Active Not RecruitingNCT04288726What this trial is testingAllogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive LymphomasWho this might be right forExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma Baylor College of Medicine 27
Testing effectiveness (Phase 2)Ended earlyNCT05099549What this trial is testingSafety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing CancersWho this might be right forSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more NKGen Biotech, Inc. 11
Testing effectiveness (Phase 2)UnknownNCT02409576What this trial is testingPilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for SarcomasWho this might be right forEwing SarcomaRhabdomyosarcoma National University Hospital, Singapore 20
Not applicableUnknownNCT02963155What this trial is testingStudy of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to CastrationWho this might be right forMetastatic Prostate Cancer Institut Paoli-Calmettes 30